These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7564565)

  • 21. Peroxisome biogenesis in Saccharomyces cerevisiae.
    Kunau WH; Hartig A
    Antonie Van Leeuwenhoek; 1992 Aug; 62(1-2):63-78. PubMed ID: 1444337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biogenesis of peroxisomes in fetal liver.
    Espeel M; Depreter M; Nardacci R; D'Herde K; Kerckaert I; Stefanini S; Roels F
    Microsc Res Tech; 1997 Dec; 39(5):453-66. PubMed ID: 9408912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of hepatocarcinogenicity of peroxisome-proliferating drugs and chemicals.
    Lake BG
    Annu Rev Pharmacol Toxicol; 1995; 35():483-507. PubMed ID: 7598504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidative DNA damage caused by persistent peroxisome proliferation: its role in hepatocarcinogenesis.
    Reddy JK; Rao MS
    Mutat Res; 1989 Sep; 214(1):63-8. PubMed ID: 2671702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased hydroxyl radical production in liver peroxisomal fractions from rats treated with peroxisome proliferators.
    Elliott BM; Dodd NJ; Elcombe CR
    Carcinogenesis; 1986 May; 7(5):795-9. PubMed ID: 3009047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of the major integral membrane protein of mouse liver peroxisomes by peroxisome proliferators.
    Chen N; Crane DI
    Biochem J; 1992 Apr; 283 ( Pt 2)(Pt 2):605-10. PubMed ID: 1575703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increases in tissue levels of ubiquinone in association with peroxisome proliferation.
    Aberg F; Zhang Y; Teclebrhan H; Appelkvist EL; Dallner G
    Chem Biol Interact; 1996 Jan; 99(1-3):205-18. PubMed ID: 8620569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PPAR: a mediator of peroxisome proliferator action.
    Green S
    Mutat Res; 1995 Dec; 333(1-2):101-9. PubMed ID: 8538617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Peroxisomal diseases--oxygen and free radicals].
    Kremser K; Kovacs W; Stangl H
    Wien Klin Wochenschr; 1995; 107(22):690-3. PubMed ID: 8533430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coordinate induction of acyl-CoA binding protein, fatty acid binding protein and peroxisomal beta-oxidation by peroxisome proliferators.
    Vanden Heuvel JP; Sterchele PF; Nesbit DJ; Peterson RE
    Biochim Biophys Acta; 1993 Jun; 1177(2):183-90. PubMed ID: 8499488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excessive accumulation of autofluorescent lipofuscin in the liver during hepatocarcinogenesis by methyl clofenapate and other hypolipidemic peroxisome proliferators.
    Reddy JK; Lalwani ND; Reddy MK; Qureshi SA
    Cancer Res; 1982 Jan; 42(1):259-66. PubMed ID: 7053853
    [No Abstract]   [Full Text] [Related]  

  • 32. [Biogenesis of peroxisome--targeting signal and peroxisome assembly factor].
    Fujiki Y
    No To Hattatsu; 1992 Mar; 24(2):181-5. PubMed ID: 1567655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans.
    Reddy JK; Lalwai ND
    Crit Rev Toxicol; 1983; 12(1):1-58. PubMed ID: 6360536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the peroxisomal matrix protein import system of different organisms. Exploration of possibilities for developing inhibitors of the import system of trypanosomatids for anti-parasite chemotherapy.
    Galland N; Michels PA
    Eur J Cell Biol; 2010 Sep; 89(9):621-37. PubMed ID: 20435370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific changes in the protein composition of rat liver in response to the peroxisome proliferators ciprofibrate, Wy-14,643 and di-(2-ethylhexyl)phthalate.
    Watanabe T; Lalwani ND; Reddy JK
    Biochem J; 1985 May; 227(3):767-75. PubMed ID: 4004798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The surprising complexity of peroxisome biogenesis.
    Olsen LJ
    Plant Mol Biol; 1998 Sep; 38(1-2):163-89. PubMed ID: 9738966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunochemical identity of peroxisomal enoyl-CoA hydratase with the peroxisome-proliferation-associated 80,000 mol wt polypeptide in rat liver.
    Reddy MK; Qureshi SA; Hollenberg PF; Reddy JK
    J Cell Biol; 1981 Jun; 89(3):406-17. PubMed ID: 6788778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An overview of peroxisome proliferator-induced hepatocarcinogenesis.
    Rao MS; Reddy JK
    Environ Health Perspect; 1991 Jun; 93():205-9. PubMed ID: 1685443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peroxisome proliferation and oxidative stress mediated by activated oxygen species in plant peroxisomes.
    Palma JM; Garrido M; Rodríguez-García MI; del Río LA
    Arch Biochem Biophys; 1991 May; 287(1):68-74. PubMed ID: 1897996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormality in catalase import into peroxisomes leads to severe neurological disorder.
    Sheikh FG; Pahan K; Khan M; Barbosa E; Singh I
    Proc Natl Acad Sci U S A; 1998 Mar; 95(6):2961-6. PubMed ID: 9501198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.